VeriSign (VRSN) is down 3.9% today. Here is some analysis on what might have caused this price movement.
Analysis: A single, definitive headline catalyst was not obvious from company announcements this morning, so the move looks consistent with profit-taking and sentiment-driven selling. Recent insider-sale disclosures and ongoing investor sensitivity to the outlook for .com/.net pricing and agreements could be adding to the pressure.
Details:
Sources:
SEC, VeriSign Investor Relations, The Motley Fool
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$VRSN Insider Trading Activity
$VRSN insiders have traded $VRSN stock on the open market 64 times in the past 6 months. Of those trades, 2 have been purchases and 62 have been sales.
Here’s a breakdown of recent trading of $VRSN stock by insiders over the last 6 months:
- D JAMES BIDZOS (Exec. Chairman, Pres, & CEO) has made 0 purchases and 46 sales selling 30,300 shares for an estimated $7,601,304.
- DANNY R MCPHERSON (EVP - Technology & CSO) sold 5,000 shares for an estimated $1,355,106
- THOMAS C INDELICARTO (EVP, Gen Counsel & Secretary) has made 0 purchases and 15 sales selling 4,985 shares for an estimated $1,268,514.
- COURTNEY D ARMSTRONG has made 2 purchases buying 16 shares for an estimated $4,929 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$VRSN Hedge Fund Activity
We have seen 420 institutional investors add shares of $VRSN stock to their portfolio, and 503 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TROY ASSET MANAGEMENT LTD added 783,354 shares (+inf%) to their portfolio in Q1 2026, for an estimated $194,553,799
- D. E. SHAW & CO., INC. removed 669,921 shares (-90.0%) from their portfolio in Q4 2025, for an estimated $162,757,306
- AMERIPRISE FINANCIAL INC removed 475,218 shares (-78.4%) from their portfolio in Q1 2026, for an estimated $118,025,142
- POINT72 ASSET MANAGEMENT, L.P. removed 474,021 shares (-48.4%) from their portfolio in Q1 2026, for an estimated $117,727,855
- QUBE RESEARCH & TECHNOLOGIES LTD removed 459,420 shares (-92.3%) from their portfolio in Q1 2026, for an estimated $114,101,551
- ROYAL BANK OF CANADA added 308,411 shares (+296.3%) to their portfolio in Q1 2026, for an estimated $76,596,955
- HAWK RIDGE CAPITAL MANAGEMENT LP added 298,895 shares (+48.5%) to their portfolio in Q1 2026, for an estimated $74,233,562
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$VRSN Congressional Stock Trading
Members of Congress have traded $VRSN stock 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $VRSN stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 02/10, 12/19 and 1 sale worth up to $15,000 on 03/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$VRSN Price Targets
Multiple analysts have issued price targets for $VRSN recently. We have seen 3 analysts offer price targets for $VRSN in the last 6 months, with a median target of $320.0.
Here are some recent targets:
- Robert Oliver from Baird set a target price of $355.0 on 04/24/2026
- Alexei Gogolev from JP Morgan set a target price of $278.0 on 04/24/2026
- Jamesmichael Sherman-Lewis from Citigroup set a target price of $320.0 on 04/24/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.